Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP230616.RAaTc4JvJhw0VAvanyJQNwH9zWFTClVACHLn6uUcY-_Mk130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230616.RAaTc4JvJhw0VAvanyJQNwH9zWFTClVACHLn6uUcY-_Mk130_provenance.
• NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443037.RA6xdnURQ8tgcni5ZSvzq1to0-PIGBdo057BNSMKdN354130_provenance.
• NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.
• NP556110.RAWEmoNZOZRSm56gOdnZmQXBaO_DdxgoerVU2jxdKUNis130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556110.RAWEmoNZOZRSm56gOdnZmQXBaO_DdxgoerVU2jxdKUNis130_provenance.
• NP556199.RAZHqdyHzdGQ01zkdjmiaRZQmAZC1KDrCBinSPDJbKXFM130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556199.RAZHqdyHzdGQ01zkdjmiaRZQmAZC1KDrCBinSPDJbKXFM130_provenance.
• NP876136.RA88HVKpZxCYxRkf60QSus0Sp1ys93fSNwTgH6FhXha6g130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876136.RA88HVKpZxCYxRkf60QSus0Sp1ys93fSNwTgH6FhXha6g130_provenance.
• NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636616.RAKy_Uq-5j44gEhg1LxsrPDIkdhJlgficstxZRLwsGLno130_provenance.
• NP258546.RAi4ViUTWIJPRouii0lgNsiH6FkK3gi0Fcx5c5P8Nu9vc130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258546.RAi4ViUTWIJPRouii0lgNsiH6FkK3gi0Fcx5c5P8Nu9vc130_provenance.
• NP258612.RAsj-IzNT8yyEVRoXh08dTGJM4PhN8L8LGPWde-XPoyCw130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258612.RAsj-IzNT8yyEVRoXh08dTGJM4PhN8L8LGPWde-XPoyCw130_provenance.
• NP1312949.RACPwqECQiNgbEGN39BG1CAVHWakZAV1PJkngZCXx4Cxc130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312949.RACPwqECQiNgbEGN39BG1CAVHWakZAV1PJkngZCXx4Cxc130_provenance.
• NP929448.RAP0MxjSa8H-rs2FfETBMDKUUHumyt2dlyFTRfXk2G5q8130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929448.RAP0MxjSa8H-rs2FfETBMDKUUHumyt2dlyFTRfXk2G5q8130_provenance.
• NP1312948.RAcV7GkoMIXCn_iDgaUlIoEDycEV_ATvPZ2Nk3VbILkPU130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312948.RAcV7GkoMIXCn_iDgaUlIoEDycEV_ATvPZ2Nk3VbILkPU130_provenance.
• NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.
• NP1312946.RAkT5sD3m87WiGJfSHLlHpTaA73pQBGEQKej2OvONCjZc130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312946.RAkT5sD3m87WiGJfSHLlHpTaA73pQBGEQKej2OvONCjZc130_provenance.
• NP1312951.RAPYykaT2CQ2EmFHoXorwVTewa0mE_1d600UiyikZRSYI130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312951.RAPYykaT2CQ2EmFHoXorwVTewa0mE_1d600UiyikZRSYI130_provenance.
• NP1312947.RAyrUvDmMTbuqjMNlgDXCFtDNWlaMIiYhdj0QMOf79Y3Y130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312947.RAyrUvDmMTbuqjMNlgDXCFtDNWlaMIiYhdj0QMOf79Y3Y130_provenance.